Azienda Sociosanitaria Territoriale Santi Paolo E Carlo
- Address
- lock Available on a paid plan
Virus Diseases and Infectious Disease Research
At Azienda Sociosanitaria Territoriale Santi Paolo E Carlo in Milan, a major share of the clinical research focuses on HIV infections, HIV-1 infection, and mpox virus disease. These studies are designed to assess new antiviral options, improve treatment switching strategies, and better understand outcomes in people living with or newly diagnosed with viral infections.
- Evaluation of new antiviral therapies for HIV-1
- Studies on treatment switching and long-term control in HIV
- Clinical observations in mpox virus disease to guide care
The site’s infectious diseases team is building evidence to support safer, more effective management of viral illnesses in everyday practice.
Respiratory Tract Diseases and Pulmonary Medicine
Research in respiratory diseases includes chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and progressive pulmonary fibrosis. These trials aim to reduce flare-ups, slow lung function decline, and evaluate whether emerging treatments can improve breathing and quality of life for people with chronic lung disease.
- Testing therapies for COPD with frequent exacerbations
- Assessing treatments for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
- Exploring ways to lower disease burden in long-term lung disease
This area reflects a strong interest in improving outcomes for patients with complex and progressive respiratory conditions.
Eye Diseases and Ophthalmology
The site is also active in ophthalmic research, with studies in glaucoma, neurotrophic keratopathy, and seasonal allergic conjunctivitis. These trials are focused on preserving vision, easing eye symptoms, and evaluating new approaches that may help protect eye health in people with chronic or inflammatory eye disorders.
- Improving visual field preservation in glaucoma
- Testing treatments for corneal nerve damage in neurotrophic keratopathy
- Relieving symptoms of seasonal allergic conjunctivitis
The ophthalmology studies combine symptom control with efforts to maintain long-term vision and eye function.
Cardiovascular Diseases and Acute Care Research
In the cardiovascular field, clinical trials at this site examine heart failure and pulmonary hypertension due to left heart disease, stroke, and the reversal of anticoagulation in urgent surgical settings. The research is aimed at improving survival, reducing complications, and supporting safer treatment decisions in time-sensitive cardiovascular care.
- Evaluating therapies for heart failure with pulmonary hypertension
- Studying treatment effectiveness after stroke
- Improving bleeding control and urgent care for patients on anticoagulants
These studies address both chronic cardiovascular disease and emergency management needs.
Digestive System Diseases and Metabolic-Renal Research
The site’s work in digestive system diseases includes research on cholestasis, while related studies also address chronic kidney disease associated with type 1 diabetes. Together, these trials are examining new ways to reduce symptoms, protect organ function, and improve disease control in patients with long-term metabolic and hepatobiliary conditions.
- Testing treatments for cholestatic pruritus
- Evaluating kidney-protective strategies in chronic kidney disease with type 1 diabetes
- Supporting better management of complex multi-organ disease
At this Milan hospital, the research portfolio shows a broad interest in chronic conditions that affect quality of life and long-term health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 19 therapeutic areas and 15 of 154 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 125 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 45 by active trials.
- 1Boehringer Ingelheim Espana S.A.3active
lock +44 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB6trials
lock +21 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Sociosanitaria Territoriale Santi Paolo E Carlo
lock Showing 1 of 93 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2/3, Double-Blind, Placebo-Controlled Study of BHV-8000 in Participants with Early Parkinson’s Disease | Biohaven Therapeutics Ltd. | Phase IV | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 154 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamethasone | 6 | Unknown | 2021-09-28 | 2024-11-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.